Hims & Hers Health Faces Securities Fraud Lawsuit Over Privacy and Billing Practices
Hims & Hers Health, Inc. is facing a securities fraud class action lawsuit alleging deceptive privacy and billing practices, which investors claim led to a stock decline exceeding 14%.

Hims & Hers Health, Inc. is facing a securities fraud class action lawsuit filed by investors alleging deceptive privacy and billing practices. The lawsuit claims these practices led to a significant decline in the company's stock value, reportedly over 14%.
The action is being brought by investors represented by Kahn Swick & Foti, LLC (KSF) and KSF partner Charles C. Foti, Jr. Investors with substantial losses are reminded they have until November 2, 2026, to file lead plaintiff applications.
Allegations in the lawsuit center on claims that Hims & Hers Health made false or misleading statements regarding its privacy and billing policies. Investors contend they purchased the company's securities purchased at artificially inflated prices based on these purported misrepresentations.
The class action seeks to recover damages for investors who purchased Hims & Hers Health securities. The law firms are encouraging eligible investors to learn more about their legal options and the upcoming deadline.